Largest Diagnostics & Research Companies by Market Cap
The Diagnostics & Research sector has 167 publicly listed stocks with a combined market cap of $981.08 Billion. Thermo Fisher Scientific Inc leads the sector with a market cap of $216.70 Billion. This ranking covers all Diagnostics & Research stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$981.08 Billion
Companies Listed
167
Largest Company
Thermo Fisher Scientific …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Thermo Fisher Scientific Inc
NYSE:TMO |
$216.70 Billion | $216.70 Billion | USA | $576.77 | +0.05% | +9.56% | 51.02 Million |
| 2 |
Danaher Corporation
NYSE:DHR |
$138.56 Billion | $138.56 Billion | USA | $196.17 | -0.16% | +9.51% | 138.08 Million |
| 3 |
WuXi AppTec Co Ltd
SHG:603259 |
$45.41 Billion | CN¥310.35 Billion | China | CN¥125.48 | -0.81% | -0.33% | 1.68 Billion |
| 4 |
IDEXX Laboratories Inc
NASDAQ:IDXX |
$43.83 Billion | $43.83 Billion | USA | $558.80 | -1.93% | +2.53% | 14.69 Million |
| 5 |
LONZA GROUP UNSP.ADR 1/10
F:LO3A |
$41.04 Billion | €35.10 Billion | Germany | €54.50 | +0.00% | -3.54% | 230.00 |
| 6 |
Agilent Technologies Inc
NYSE:A |
$39.26 Billion | $39.26 Billion | USA | $138.71 | -1.13% | +3.93% | 48.03 Million |
| 7 |
Natera Inc
NASDAQ:NTRA |
$38.62 Billion | $38.62 Billion | USA | $269.66 | +6.24% | +2.06% | 29.87 Million |
| 8 |
Waters Corporation
NYSE:WAT |
$34.91 Billion | $34.91 Billion | USA | $380.30 | +0.22% | +2.56% | 18.86 Million |
| 9 |
Lonza Group AG
SW:LONN |
$34.36 Billion | CHF27.18 Billion | Switzerland | CHF570.20 | -0.80% | +6.30% | 3.84 Million |
| 10 |
IQVIA Holdings Inc
NYSE:IQV |
$28.43 Billion | $28.43 Billion | USA | $237.79 | -3.95% | +19.78% | 31.96 Million |
| 11 |
Labcorp Holdings Inc.
MX:LH |
$22.45 Billion | MX$390.06 Billion | Mexico | MX$4705.14 | +0.00% | -4.17% | 1.93K |
| 12 |
Mettler-Toledo International Inc
NYSE:MTD |
$21.79 Billion | $21.79 Billion | USA | $1380.61 | -0.56% | +7.37% | 3.74 Million |
| 13 |
Laboratory Corporation of America Holdings
NYSE:LH |
$21.71 Billion | $21.71 Billion | USA | $315.53 | +2.73% | +12.10% | 16.74 Million |
| 14 |
Quest Diagnostics Incorporated
NYSE:DGX |
$20.74 Billion | $20.74 Billion | USA | $234.30 | -0.39% | +11.66% | 26.48 Million |
| 15 |
EXACT Sciences Corporation
NASDAQ:EXAS |
$19.80 Billion | $19.80 Billion | USA | $1819.87 | +0.25% | -2.61% | 37.42 Million |
| 16 |
Illumina Inc
NASDAQ:ILMN |
$18.34 Billion | $18.34 Billion | USA | $205.09 | +5.27% | +7.45% | 42.89 Million |
| 17 |
Medpace Holdings Inc
NASDAQ:MEDP |
$15.19 Billion | $15.19 Billion | USA | $578.30 | -1.13% | +9.50% | 9.33 Million |
| 18 |
Guardant Health Inc
NASDAQ:GH |
$12.69 Billion | $12.69 Billion | USA | $152.35 | +5.75% | +1.06% | 73.98 Million |
| 19 |
Revvity Inc.
NYSE:RVTY |
$12.20 Billion | $12.20 Billion | USA | $113.54 | +0.15% | +2.71% | 32.46 Million |
| 20 |
Eurofins Scientific SE
F:ESF0 |
$11.18 Billion | €9.56 Billion | Germany | €59.14 | +0.03% | +0.92% | 2.33K |
| 21 |
WuXi AppTec Co. Ltd
F:WX8 |
$10.42 Billion | €8.92 Billion | Germany | €17.47 | -0.17% | +0.59% | 11.32K |
| 22 |
Eurofins Scientific SE
PA:ERF |
$10.22 Billion | €8.74 Billion | France | €68.60 | -0.06% | -2.81% | 5.88 Million |
| 23 |
ICON PLC
NASDAQ:ICLR |
$9.25 Billion | $9.25 Billion | USA | $165.53 | -7.10% | -1.05% | 20.74 Million |
| 24 |
Charles River Laboratories
NYSE:CRL |
$9.14 Billion | $9.14 Billion | USA | $234.62 | -0.08% | +7.28% | 18.57 Million |
| 25 |
Biomerieux SA
PA:BIM |
$8.48 Billion | €7.25 Billion | France | €71.85 | -1.37% | +2.86% | 4.42 Million |
| 26 |
Sonic Healthcare Ltd
AU:SHL |
$7.87 Billion | AU$11.12 Billion | Australia | AU$22.50 | -0.97% | +8.17% | 38.09 Million |
| 27 |
Qiagen NV
NYSE:QGEN |
$7.79 Billion | $7.79 Billion | USA | $41.45 | -0.86% | +2.17% | 62.23 Million |
| 28 |
ICON Public Limited Company
F:IJF |
$7.52 Billion | €6.43 Billion | Germany | €154.00 | -1.53% | +6.87% | 0.00 |
| 29 |
Hangzhou Tigermed Consulting
SHE:300347 |
$5.29 Billion | CN¥36.18 Billion | China | CN¥49.03 | -3.45% | -0.53% | 619.46 Million |
| 30 |
Sotera Health Co
NASDAQ:SHC |
$4.64 Billion | $4.64 Billion | USA | $17.85 | +1.83% | +3.24% | 70.87 Million |
| 31 |
RadNet Inc
NASDAQ:RDNT |
$4.58 Billion | $4.58 Billion | USA | $62.69 | -1.07% | +5.86% | 19.95 Million |
| 32 |
BillionToOne, Inc. Class A Common Stock
NASDAQ:BLLN |
$4.57 Billion | $4.57 Billion | USA | $139.59 | +5.34% | +8.01% | 15.22 Million |
| 33 |
Twist Bioscience Corp
NASDAQ:TWST |
$4.31 Billion | $4.31 Billion | USA | $91.33 | +6.86% | -3.06% | 36.56 Million |
| 34 |
Joinn Laboratories(China)Co
SHG:603127 |
$3.69 Billion | CN¥25.25 Billion | China | CN¥40.05 | -8.85% | -16.67% | 1.34 Billion |
| 35 |
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB |
$3.39 Billion | Rs313.72 Billion | India | Rs1878.80 | -0.20% | +10.58% | 11.52 Million |
| 36 |
Veracyte Inc
NASDAQ:VCYT |
$2.83 Billion | $2.83 Billion | USA | $59.78 | +7.31% | +3.05% | 26.67 Million |
| 37 |
GRAIL, LLC
NASDAQ:GRAL |
$2.58 Billion | $2.58 Billion | USA | $71.14 | +12.14% | +0.68% | 12.70 Million |
| 38 |
BGI Genomics Co Ltd
SHE:300676 |
$2.26 Billion | CN¥15.43 Billion | China | CN¥36.89 | -1.18% | -1.60% | 187.18 Million |
| 39 |
Vimian Group AB
ST:VIMIAN |
$1.95 Billion | Skr18.15 Billion | Sweden | Skr34.50 | -0.86% | +1.47% | 6.53 Million |
| 40 |
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
$1.84 Billion | CN¥12.57 Billion | China | CN¥27.14 | -1.02% | +0.11% | 207.95 Million |
| 41 |
Fleury S.A.
SA:FLRY3 |
$1.81 Billion | R$9.23 Billion | Brazil | R$16.97 | +0.83% | +1.92% | 46.64 Million |
| 42 |
Syngene International Limited
NSE:SYNGENE |
$1.73 Billion | Rs160.36 Billion | India | Rs399.20 | -3.63% | -1.77% | 36.06 Million |
| 43 |
Vijaya Diagnostic Centre Limited
NSE:VIJAYA |
$1.51 Billion | Rs139.96 Billion | India | Rs1360.20 | -0.86% | +3.59% | 7.29 Million |
| 44 |
Zhejiang DiAn Diagnostics Co
SHE:300244 |
$1.49 Billion | CN¥10.19 Billion | China | CN¥16.30 | -2.92% | -5.23% | 977.70 Million |
| 45 |
CareDx Inc
NASDAQ:CDNA |
$1.42 Billion | $1.42 Billion | USA | $38.10 | +7.60% | +0.85% | 24.92 Million |
| 46 |
GeneDx Holdings Corp.
NASDAQ:WGS |
$1.18 Billion | $1.18 Billion | USA | $68.96 | +8.28% | +10.16% | 16.87 Million |
| 47 |
NeoGenomics Inc
NASDAQ:NEO |
$1.13 Billion | $1.13 Billion | USA | $15.88 | +3.99% | +13.35% | 77.17 Million |
| 48 |
Thyrocare Technologies Limited
NSE:THYROCARE |
$1.02 Billion | Rs94.14 Billion | India | Rs591.45 | +1.97% | +6.00% | 25.30 Million |
| 49 |
Amoy Diagnostics Co Ltd
SHE:300685 |
$991.19 Million | CN¥6.77 Billion | China | CN¥17.30 | +0.00% | -1.31% | 224.90 Million |
| 50 |
Beijing Strong Biotechnologies Inc
SHE:300406 |
$976.35 Million | CN¥6.67 Billion | China | CN¥11.38 | +0.53% | +1.70% | 118.62 Million |
| 51 |
Opko Health Inc
NASDAQ:OPK |
$860.81 Million | $860.81 Million | USA | $1.34 | -2.20% | +13.14% | 113.54 Million |
| 52 |
Clinica Baviera
MC:CBAV |
$842.36 Million | €720.51 Million | Spain | €58.60 | +1.03% | +0.69% | 70.23K |
| 53 |
Shanghai Runda Med Tech Co
SHG:603108 |
$834.78 Million | CN¥5.70 Billion | China | CN¥9.45 | -0.53% | +2.38% | 548.94 Million |
| 54 |
Maccura Biotechnology Co Ltd
SHE:300463 |
$794.57 Million | CN¥5.43 Billion | China | CN¥8.98 | +0.67% | +2.39% | 221.87 Million |
| 55 |
Castle Biosciences Inc
NASDAQ:CSTL |
$722.76 Million | $722.76 Million | USA | $26.79 | +9.53% | +7.98% | 8.14 Million |
| 56 |
Diagnósticos da América S.A
SA:DASA3 |
$647.40 Million | R$3.30 Billion | Brazil | R$2.64 | +0.38% | -7.37% | 19.67 Million |
| 57 |
Personalis Inc
NASDAQ:PSNL |
$626.23 Million | $626.23 Million | USA | $12.28 | +4.69% | -1.52% | 124.85 Million |
| 58 |
Cowealth Medical China Co.Ltd.
SHG:603122 |
$581.89 Million | CN¥3.98 Billion | China | CN¥9.99 | -2.73% | +3.74% | 421.17 Million |
| 59 |
HANGZHOU TIGERMED CO. H 1
F:5HZ1 |
$581.54 Million | €497.42 Million | Germany | €4.04 | -4.72% | +1.51% | 0.00 |
| 60 |
Integral Diagnostics Ltd
AU:IDX |
$551.49 Million | AU$779.42 Million | Australia | AU$2.09 | +0.00% | +1.46% | 15.22 Million |
| 61 |
Guangdong Hybribio Biotech Co Ltd
SHE:300639 |
$531.67 Million | CN¥3.63 Billion | China | CN¥5.62 | +2.93% | +12.18% | 421.70 Million |
| 62 |
Fulgent Genetics Inc
NASDAQ:FLGT |
$527.83 Million | $527.83 Million | USA | $20.21 | +2.90% | +3.48% | 5.94 Million |
| 63 |
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
$507.83 Million | CN¥3.47 Billion | China | CN¥15.37 | -2.78% | +10.34% | 503.77 Million |
| 64 |
Myriad Genetics Inc
NASDAQ:MYGN |
$507.19 Million | $507.19 Million | USA | $5.37 | +6.55% | -5.12% | 30.30 Million |
| 65 |
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060 |
$491.72 Million | CN¥3.36 Billion | China | CN¥8.39 | -2.10% | +0.36% | 229.25 Million |
| 66 |
Lumibird SA
PA:LBIRD |
$489.86 Million | €419.00 Million | France | €26.25 | +0.19% | -5.91% | 873.29K |
| 67 |
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439 |
$479.15 Million | CN¥3.27 Billion | China | CN¥8.52 | +0.95% | +3.27% | 90.93 Million |
| 68 |
SMO ClinPlus Co. Ltd.
SHE:301257 |
$433.30 Million | CN¥2.96 Billion | China | CN¥37.48 | -9.05% | -25.04% | 200.62 Million |
| 69 |
Berry Genomics Co Ltd
SHE:000710 |
$412.30 Million | CN¥2.82 Billion | China | CN¥7.97 | -1.36% | +3.91% | 251.80 Million |
| 70 |
Voxel S.A.
WAR:VOX |
$363.04 Million | zł1.32 Billion | Poland | zł125.60 | +0.00% | +1.78% | 406.33K |
| 71 |
Chemclin Diagnostics Co. Ltd. A
SHG:688468 |
$341.60 Million | CN¥2.33 Billion | China | CN¥5.82 | -0.17% | +3.56% | 84.82 Million |
| 72 |
Integrated Diagnostics Holdings PLC
LSE:IDHC |
$339.49 Million | $339.49 Million | UK | $0.58 | -2.67% | +12.74% | 6.06 Million |
| 73 |
Metropolis Healthcare Limited
NSE:METROPOLIS |
$328.03 Million | Rs30.33 Billion | India | Rs585.20 | -1.08% | +2.65% | 8.07 Million |
| 74 |
Australian Clinical Labs Ltd
AU:ACL |
$318.70 Million | AU$450.41 Million | Australia | AU$2.40 | -1.23% | +3.00% | 13.41 Million |
| 75 |
Prenetics Global Ltd
NASDAQ:PRE |
$293.36 Million | $293.36 Million | USA | $19.24 | +6.77% | -11.99% | 5.53 Million |
| 76 |
Spectral Med Inc
TO:EDT |
$292.82 Million | CA$404.79 Million | Canada | CA$1.40 | +0.72% | +3.70% | 1.30 Million |
| 77 |
Vimta Labs Limited
NSE:VIMTALABS |
$292.26 Million | Rs27.02 Billion | India | Rs605.45 | +1.07% | +3.69% | 15.08 Million |
| 78 |
INTERGRATED DIA.H DL 025
F:8I8 |
$288.34 Million | €246.63 Million | Germany | €0.48 | +9.50% | +19.21% | 0.00 |
| 79 |
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
$253.71 Million | CN¥1.73 Billion | China | CN¥43.27 | +0.19% | +7.16% | 13.53 Million |
| 80 |
Biodesix Inc
NASDAQ:BDSX |
$210.64 Million | $210.64 Million | USA | $21.34 | +4.69% | -0.26% | 1.88 Million |
| 81 |
Monash Ivf Group Ltd
AU:MVF |
$191.61 Million | AU$270.80 Million | Australia | AU$0.70 | +1.46% | +3.73% | 12.70 Million |
| 82 |
Healius Ltd
AU:HLS |
$187.54 Million | AU$265.05 Million | Australia | AU$0.37 | -2.67% | +2.82% | 60.65 Million |
| 83 |
Krsnaa Diagnostics Limited
NSE:KRSNAA |
$183.84 Million | Rs17.00 Billion | India | Rs524.05 | -1.76% | -3.26% | 1.23 Million |
| 84 |
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX |
$148.53 Million | $148.53 Million | USA | $4.60 | +5.26% | -7.82% | 4.33 Million |
| 85 |
Selvita S.A.
WAR:SLV |
$134.10 Million | zł487.24 Million | Poland | zł26.55 | -0.19% | +1.34% | 684.57K |
| 86 |
Cancer Rop Co. Ltd.
KQ:180400 |
$132.27 Million | ₩195.18 Billion | Korea | ₩1983.00 | -1.34% | -7.98% | 1.54 Million |
| 87 |
Prodia Widyahusada Tbk PT
JK:PRDA |
$129.64 Million | Rp2.21 Trillion | Indonesia | Rp2360.00 | +0.85% | -1.26% | 24.55 Million |
| 88 |
Green Cross Lab Cell Corporation
KQ:144510 |
$129.43 Million | ₩190.99 Billion | Korea | ₩12710.00 | -0.78% | -1.93% | 1.14 Million |
| 89 |
Fonar Corporation
NASDAQ:FONR |
$117.84 Million | $117.84 Million | USA | $19.09 | +0.00% | +0.95% | 2.89 Million |
| 90 |
MDxHealth SA ADR
NASDAQ:MDXH |
$111.46 Million | $111.46 Million | USA | $2.17 | -4.82% | -6.06% | 5.64 Million |
| 91 |
Exagen Inc
NASDAQ:XGN |
$103.65 Million | $103.65 Million | USA | $4.67 | +7.36% | -5.47% | 5.44 Million |
| 92 |
Centro de Imagem Diagnósticos S.A
SA:AALR3 |
$95.64 Million | R$487.43 Million | Brazil | R$3.20 | -1.54% | -7.25% | 1.42 Million |
| 93 |
BioPorto
CO:BIOPOR |
$90.63 Million | Dkr579.26 Million | Denmark | Dkr1.17 | -3.31% | -5.65% | 7.24 Million |
| 94 |
OncoCyte Corp
NASDAQ:OCX |
$90.37 Million | $90.37 Million | USA | $3.16 | +0.00% | +0.00% | 1.44 Million |
| 95 |
Bionet
TWO:1784 |
$88.91 Million | NT$2.82 Billion | Taiwan | NT$56.10 | -0.36% | -7.73% | 5.74 Million |
| 96 |
Eurofins-Cerep SA
PA:ALECR |
$87.26 Million | €74.64 Million | France | €16300.00 | +0.00% | +0.00% | 14.00 |
| 97 |
Scope Fluidics SA
WAR:SCP |
$86.72 Million | zł315.12 Million | Poland | zł115.60 | -1.20% | -2.20% | 34.05K |
| 98 |
SCOPE FLUIDICS SA ZY-10
F:S84 |
$83.90 Million | €71.76 Million | Germany | €22.65 | -2.79% | -3.41% | 0.00 |
| 99 |
Burning Rock Biotech Ltd
NASDAQ:BNR |
$78.00 Million | $78.00 Million | USA | $8.85 | +0.34% | -3.17% | 380.99K |
| 100 |
JOONGANG DNM Co.Ltd
KQ:051980 |
$63.49 Million | ₩93.68 Billion | Korea | ₩845.00 | +0.00% | -14.21% | 25.70 Million |
| 101 |
DIVA Laboratories Ltd
TWO:4153 |
$58.59 Million | NT$1.86 Billion | Taiwan | NT$31.70 | +2.26% | +1.60% | 334.42K |
| 102 |
Pangaea Oncology S.A.
MC:PANG |
$56.33 Million | €48.18 Million | Spain | €1.55 | +0.00% | +0.00% | 2.37K |
| 103 |
Access Bio Inc
KQ:950130 |
$48.87 Million | ₩72.11 Billion | Korea | ₩2050.00 | +1.49% | -8.48% | 1.93 Million |
| 104 |
Optipharm.CO.LTD
KQ:153710 |
$44.54 Million | ₩65.72 Billion | Korea | ₩4480.00 | -1.65% | -4.58% | 236.61K |
| 105 |
Cytogen Inc
KQ:217330 |
$44.17 Million | ₩65.17 Billion | Korea | ₩2825.00 | -2.59% | -6.92% | 1.85 Million |
| 106 |
Cryosite Ltd
AU:CTE |
$41.44 Million | AU$58.57 Million | Australia | AU$1.20 | +0.00% | +0.00% | 26.85K |
| 107 |
P&K Skin Research Center Co. Ltd
KQ:347740 |
$33.41 Million | ₩49.30 Billion | Korea | ₩1707.00 | +0.95% | -0.29% | 757.51K |
| 108 |
Precipio Inc
NASDAQ:PRPO |
$31.61 Million | $31.61 Million | USA | $21.19 | -3.02% | -9.75% | 2.34 Million |
| 109 |
INIFY LABORATORIES AB
F:WY60 |
$30.74 Million | €26.29 Million | Germany | €0.60 | +19.00% | +3.48% | 0.00 |
| 110 |
Genoray Co. Ltd
KQ:122310 |
$27.25 Million | ₩40.21 Billion | Korea | ₩3310.00 | -1.78% | -4.34% | 224.46K |
| 111 |
Biocartis Group NV
BR:BCART |
$27.24 Million | €23.30 Million | Belgium | €0.29 | +0.00% | +0.00% | 0.00 |
| 112 |
Quantum Cyber N.V.
NASDAQ:QUCY |
$25.27 Million | $25.27 Million | USA | $1.11 | +4.72% | -2.63% | 86.86 Million |
| 113 |
Gencurix Inc
KQ:229000 |
$22.58 Million | ₩33.31 Billion | Korea | ₩1422.00 | +1.57% | -11.01% | 4.57 Million |
| 114 |
NanoRepro AG
XETRA:NN6 |
$22.45 Million | €19.20 Million | Germany | €1.94 | -0.77% | -8.29% | 481.34K |
| 115 |
Microba Life Sciences Ltd
AU:MAP |
$20.68 Million | AU$29.23 Million | Australia | AU$0.05 | +2.13% | +6.67% | 11.08 Million |
| 116 |
Inoviq Ltd
AU:IIQ |
$18.93 Million | AU$26.75 Million | Australia | AU$0.19 | -2.56% | -2.56% | 15.23 Million |
| 117 |
Bcal Diagnostics Ltd
AU:BDX |
$18.26 Million | AU$25.81 Million | Australia | AU$0.07 | -4.11% | -4.11% | 1.33 Million |
| 118 |
RHYTHM Biosciences Ltd
AU:RHY |
$18.10 Million | AU$25.58 Million | Australia | AU$0.08 | -3.70% | -2.50% | 4.79 Million |
| 119 |
GeneMatrix Inc
KQ:109820 |
$17.78 Million | ₩26.23 Billion | Korea | ₩1314.00 | -2.16% | -7.66% | 800.66K |
| 120 |
Diagnos Laboratorium Utama PT Tbk
JK:DGNS |
$17.14 Million | Rp292.50 Billion | Indonesia | Rp234.00 | +0.00% | +1.74% | 10.85 Million |
| 121 |
SenzaGen AB
ST:SENZA |
$16.70 Million | Skr155.19 Million | Sweden | Skr5.26 | -0.38% | -1.87% | 195.29K |
| 122 |
Enzo Biochem Inc
NYSE:ENZ |
$16.44 Million | $16.44 Million | USA | $0.54 | +0.00% | +0.00% | 1.75K |
| 123 |
INOVIQ LTD.
F:EGQ0 |
$15.64 Million | €13.37 Million | Germany | €0.10 | -1.04% | -4.52% | 0.00 |
| 124 |
AroCell AB
ST:AROC |
$13.39 Million | Skr124.39 Million | Sweden | Skr0.54 | +0.00% | +0.00% | 724.84K |
| 125 |
Immunovia publ AB
ST:IMMNOV |
$13.10 Million | Skr121.75 Million | Sweden | Skr0.18 | +1.46% | -1.09% | 40.85 Million |
| 126 |
NSN Co. Ltd
KQ:031860 |
$12.68 Million | ₩18.71 Billion | Korea | ₩693.00 | +17.26% | +15.69% | 50.75 Million |
| 127 |
Malaysian Genomics Resource
KLSE:0155 |
$11.94 Million | RM47.54 Million | Malaysia | RM0.32 | -1.56% | +8.62% | 1.72 Million |
| 128 |
Biomaxima
WAR:BMX |
$11.51 Million | zł41.81 Million | Poland | zł9.97 | +0.00% | -1.68% | 55.79K |
| 129 |
IZOTROPIC CORP.
F:1R3 |
$11.45 Million | €9.80 Million | Germany | €0.14 | -0.69% | -4.03% | 0.00 |
| 130 |
Mainz Biomed BV
NASDAQ:MYNZ |
$9.49 Million | $9.49 Million | USA | $0.76 | -10.15% | -16.66% | 18.17 Million |
| 131 |
Check Cap Ltd
NASDAQ:CHEK |
$9.42 Million | $9.42 Million | USA | $139.00 | +0.72% | -2.80% | 22.52 Million |
| 132 |
Genetic Signatures Ltd
AU:GSS |
$9.32 Million | AU$13.17 Million | Australia | AU$0.06 | +0.00% | -4.92% | 14.90 Million |
| 133 |
Advanced Biomed Inc. Common Stock
NASDAQ:ADVB |
$8.80 Million | $8.80 Million | USA | $10.08 | -8.20% | -17.71% | 96.87 Million |
| 134 |
XWELL Inc.
NASDAQ:XWEL |
$8.64 Million | $8.64 Million | USA | $1.09 | +2.83% | +1.87% | 4.29 Million |
| 135 |
Check-Cap Ltd.
NASDAQ:MBAI |
$8.27 Million | $8.27 Million | USA | $1.07 | +2.88% | +5.94% | 1.41 Million |
| 136 |
Check-Cap Ltd
F:7CC |
$7.10 Million | €6.07 Million | Germany | €0.87 | -1.70% | +6.13% | 0.00 |
| 137 |
GENINCODE PLC LS -01
F:9PL |
$5.93 Million | €5.08 Million | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 138 |
Predilife
PA:ALPRE |
$5.73 Million | €4.90 Million | France | €1.25 | +4.17% | +19.05% | 31.55K |
| 139 |
ENDRA Life Sciences Inc
NASDAQ:NDRA |
$5.50 Million | $5.50 Million | USA | $4.33 | -2.70% | -22.82% | 792.97K |
| 140 |
Imagion Biosystems Ltd
AU:IBX |
$4.51 Million | AU$6.38 Million | Australia | AU$0.01 | +8.33% | +8.33% | 50.71 Million |
| 141 |
Avricore Health Inc
V:AVCR |
$4.03 Million | CA$5.57 Million | Canada | CA$0.06 | +10.00% | -8.33% | 915.46K |
| 142 |
Genetic Technologies Ltd
AU:GTG |
$4.01 Million | AU$5.67 Million | Australia | AU$0.04 | +0.00% | +0.00% | 0.00 |
| 143 |
Applied DNA Sciences Inc
NASDAQ:APDN |
$3.99 Million | $3.99 Million | USA | $3.09 | +3.00% | +24.10% | 1.14 Million |
| 144 |
Euroespes S.A.
MC:EEP |
$3.95 Million | €3.38 Million | Spain | €0.34 | +0.00% | +0.00% | 0.00 |
| 145 |
Leveljump Healthcare Corp
V:JUMP |
$3.84 Million | CA$5.31 Million | Canada | CA$0.06 | +0.00% | +0.00% | 0.00 |
| 146 |
Genetic Technologies Ltd
NASDAQ:GENE |
$3.71 Million | $3.71 Million | USA | $2000.60 | -1.76% | +0.93% | 7.09K |
| 147 |
StageZero Life Sciences Ltd
TO:SZLS |
$3.58 Million | CA$4.94 Million | Canada | CA$0.04 | +0.00% | +0.00% | 0.00 |
| 148 |
Centogene N.V.
NASDAQ:CNTGF |
$3.48 Million | $3.48 Million | USA | $0.12 | +0.00% | +0.00% | 126.40K |
| 149 |
Telo Genomics Corp
V:TELO |
$3.27 Million | CA$4.52 Million | Canada | CA$0.05 | -10.00% | +0.00% | 660.44K |
| 150 |
bioAffinity Technologies, Inc.
NASDAQ:BIAF |
$2.90 Million | $2.90 Million | USA | $0.64 | +10.15% | -8.97% | 8.95 Million |
Track real-time market capitalization of largest public companies in the Diagnostics & Research industry. Compare marketcap, analyze stock performance, and discover leading diagnostics & research corporations. View all industries